Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

CATX

Perspective Therapeutics (CATX)

Perspective Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:CATX
日付受信時刻ニュースソース見出しコード企業名
2025/02/2121 : 00GlobeNewswire Inc.Perspective Therapeutics to Provide Business Highlights and Report Full Year 2024 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
2025/02/1501 : 37Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
2025/02/1500 : 26Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
2025/02/0521 : 00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming February Investor ConferencesAMEX:CATXPerspective Therapeutics Inc
2025/02/0406 : 09Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
2025/01/2421 : 26Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
2025/01/2421 : 00GlobeNewswire Inc.Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers SymposiumAMEX:CATXPerspective Therapeutics Inc
2025/01/2221 : 00GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025AMEX:CATXPerspective Therapeutics Inc
2025/01/1322 : 36Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
2025/01/1322 : 00GlobeNewswire Inc.Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
2025/01/1021 : 00GlobeNewswire Inc.Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
2025/01/0806 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2025/01/0806 : 48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2025/01/0622 : 05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
2025/01/0622 : 00GlobeNewswire Inc.Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial OfficerAMEX:CATXPerspective Therapeutics Inc
2024/12/0706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2024/12/0507 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2024/12/0507 : 17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
2024/12/0507 : 15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
2024/11/2721 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2024/11/2721 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2024/11/2721 : 00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in DecemberAMEX:CATXPerspective Therapeutics Inc
2024/11/2621 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
2024/11/2121 : 30Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
2024/11/2121 : 15GlobeNewswire Inc.Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical SymposiumAMEX:CATXPerspective Therapeutics Inc
2024/11/1606 : 08GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024AMEX:CATXPerspective Therapeutics Inc
2024/11/1521 : 30Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
2024/11/1508 : 14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
2024/11/1506 : 05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
2024/11/1500 : 24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:CATX

最近閲覧した銘柄